Purchase Order 75N93024P00558
- Not listed
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $28,593.60 firm fixed-price purchase order to Cytek Biosciences, Inc. on October 15, 2024, for the FY26 UDO Initiative—Aurora 4 with Loader Service Contract. The contract, which requires ultimate completion by October 14, 2025, supports NIAID's research operations at its Bethesda, Maryland facility. This award carries no small business set-aside designation and represents a continuation of NIAID's long-standing...
- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health awarded a firm fixed-price purchase order to Cytek Biosciences, Inc. on April 23, 2025, for maintenance services of a Cytek Aurora 5 flow cytometer at the NIH campus in Bethesda, Maryland. The contract, valued at $62,816.70 with no set-aside designation, will run through April 22, 2027, with a base performance period from April 23, 2025, through April 22, 2026, and three optional one-year...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $247,248 firm fixed price purchase order to Cytek Biosciences, Inc. for a Cytek Aurora 4 Laser flow cytometer with additional components. The solicitation sought quotes for the cytometer, a basic startup training kit, and shipping and handling services to support NIAID's research activities. Cytek Biosciences will deliver the requested products and services from its Fremont, California location by...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract worth $23,226.00 to Cytek Biosciences, Inc., a for-profit manufacturer of advanced flow cytometry products and services. The contract is for annual maintenance and service on a Cytek Aurora flow cytometry system used by NIAID, with a completion date of June 3, 2025. This contract does not have a small...
- Cytek Biosciences, Inc., a California-based manufacturer of advanced flow cytometry systems and scientific instrumentation, has been awarded a one-year maintenance service agreement by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The contract, valued at $120,315, represents a small business set-aside purchase order with firm fixed-price terms and a performance period from April 23, 2026 through April 22, 2031. The work will be...
- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $23,919.30 firm fixed-price purchase order to Cytek Biosciences, Inc. for annual maintenance and service of an ImageStream MKII Silver flow cytometry system. The contract, awarded on May 20, 2026, will be performed at NIAID's facility in North Bethesda, Maryland, with an ultimate completion date of May 19, 2027. No small business set-aside designation was used for this award. Cytek Biosciences, headquartered in...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $36,296.80 firm fixed price purchase order to Cytek Biosciences, Inc. Cytek Biosciences Division for a one-year maintenance and service contract for a Cytek Aurora 5 Laser with loader located in Bethesda, Maryland. The solicitation sought on-site and remote service and support by factory-trained engineers, including two preventive maintenance inspections,...
- The National Institute of Allergy and Infectious Diseases awarded a $461,581.44 firm-fixed-price purchase order to Cytek Biosciences, Inc., a Fremont, California-based manufacturer of advanced flow cytometry instruments, on September 29, 2021. The contract, designated as a total small business set-aside, procures a Cytek Aurora 5 flow cytometer equipped with 5 lasers and 67 fluorescent channels, along with ancillary equipment and services including an automated sample loader, two SpectroFlo...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $10,471 firm fixed-price purchase order to Cytek Biosciences, Inc., a Fremont, California-based manufacturer of advanced flow cytometry systems and cell analysis instrumentation. The contract, awarded June 1, 2024, with an ultimate completion date of May 31, 2025, falls under the FY26 UDO Initiative and will be invoiced quarterly in arrears. The award carries no set-aside designation and represents a continuation of...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Cytek Biosciences, Inc. The $147,218.72 contract is for a 5-year service agreement to provide preventative maintenance, calibration, and technical support for Cytek's Aurora flow cytometry instruments used by NIAID at its facility in Fort Detrick, Maryland. Cytek Biosciences is a for-profit...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Cytek Biosciences, Inc. for a premium service agreement covering the Cytek Aurora 5 Laser flow cytometry system. The contract, valued at $181,979.20 with no set-aside designation, will be performed at NIAID's Bethesda, Maryland facility and is scheduled for completion by April 22, 2029. This award, issued on April 23, 2024, represents a comprehensive maintenance and support arrangement for advanced cell analysis instrumentation critical to NIAID's research missions in immunology, infectious disease, and vaccine development. Cytek Biosciences, headquartered in Fremont, California, is a leading manufacturer of flow cytometry systems and cell analysis technologies serving federal research institutions across the National Institutes of Health and other agencies. The premium service agreement typically includes preventive maintenance inspections, emergency repair support, unlimited technical assistance, parts replacement, software updates, and specialized training—ensuring optimal performance of the Aurora 5 system for NIAID's biomedical researchers. This contract reflects the established relationship between Cytek Biosciences and NIH institutes, where the company has consistently provided sophisticated instrumentation and comprehensive support services enabling complex research activities in immunological and infectious disease investigations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $29.9k | 4/16/26 | |
| P00001 | Exercise an Option | $29.9k | 3/25/25 | |
| Not listed | Not listed | $32.4k | 4/19/24 |